Evelo Biosciences, Inc.
EVLODelisted Dec 27, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001694665
Evelo Biosciences, Inc. was delisted on Dec 27, 2023; its insiders filed their last Form 4 on Nov 8, 2023; 29 institutions reported holding it in 13F filings for Q3 2023, worth $52.0M in total; no superinvestor held it.
13F holders, Q4 2022
Institutional positions in Evelo Biosciences, Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 44
- +3 vs. Q3 2022
- Shares held
- 87.0M
- +906.1K (+1.1%) vs. Q3 2022
- Total value
- $140.1M
- −$39.9M (−22.2%) vs. Q3 2022
- New holders
- 9
- 15 more added
- Sold out
- 6
- 8 more reduced
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting EVLO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 2 | $2.63K |
| Q3 2023 | 29 | $52.0M |
| Q2 2023 | 25 | $11.3M |
| Q1 2023 | 39 | $15.5M |
| Q4 2022 | 44 | $140.1M |
| Q3 2022 | 41 | $180.0M |
| Q2 2022 | 46 | $180.4M |
| Q1 2022 | 68 | $161.1M |
| Q4 2021 | 66 | $290.1M |
| Q3 2021 | 64 | $331.6M |
| Q2 2021 | 66 | $645.4M |
| Q1 2021 | 62 | $508.0M |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Evelo Biosciences, Inc.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Royal Bank of Canada | 14 | $0 | 0.00% | −130−90.3% | Reduced |
| Daiwa Securities Group Inc. | 156 | $0 | 0.00% | 00.0% | Unchanged |
| National Bank of Canada | 100 | $160 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 390 | $628 | 0.00% | +10+2.6% | Added |
| Larson Financial Group LLC | 739 | $1.19K | 0.00% | 00.0% | Unchanged |
| Fairfield Financial Advisors, LTD | 1,075 | $1.73K | 0.00% | 00.0% | Unchanged |
| China Universal Asset Management Co., Ltd. | 1,113 | $1.79K | 0.00% | +102+10.1% | Added |
| Advisor Group Holdings, Inc. | 1,500 | $2.00K | 0.00% | +1,500 | New |
| BNP Paribas Arbitrage, SA | 1,553 | $2.50K | 0.00% | +905+139.7% | Added |
| JPMorgan Chase & Co | 3,534 | $6.00K | 0.00% | −3,674−51.0% | Reduced |
| UBS Group AG | 4,564 | $7.35K | 0.00% | +1,952+74.7% | Added |
| Tower Research Capital LLC (TRC) | 5,320 | $9.00K | 0.00% | +35+0.7% | Added |
| Citadel Advisors LLC | 9,952 | $16.0K | 0.00% | +9,952 | New |
| Balyasny Asset Management LLC | 10,135 | $16.3K | 0.00% | +10,135 | New |
| Bank of New York Mellon Corp | 13,150 | $21.2K | 0.00% | 00.0% | Unchanged |
| Shay Capital LLC | 18,511 | $29.8K | 0.02% | +18,511 | New |
| Bank of America Corp | 19,279 | $31.0K | 0.00% | −29,427−60.4% | Reduced |
| Barclays PLC | 22,641 | $36.5K | 0.00% | +19,639+654.2% | Added |
| Qube Research & Technologies Ltd | 29,537 | $47.6K | 0.00% | +9,860+50.1% | Added |
| Goldman Sachs Group Inc | 31,336 | $50.5K | 0.00% | −2,729−8.0% | Reduced |
| Charles Schwab Investment Management Inc | 31,345 | $50.5K | 0.00% | 00.0% | Unchanged |
| Man Group plc | 52,637 | $84.7K | 0.00% | +52,637 | New |
| Boothbay Fund Management, LLC | 52,699 | $84.8K | 0.00% | +52,699 | New |
| Bessemer Group Inc | 61,289 | $99.0K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 78,892 | $127.0K | 0.00% | +14,567+22.6% | Added |
| 683 Capital Management, LLC | 90,291 | $145.4K | 0.01% | +90,291 | New |
| Millennium Management LLC | 93,841 | $151.0K | 0.00% | −90,822−49.2% | Reduced |
| Northern Trust Corp | 94,970 | $152.9K | 0.00% | −302−0.3% | Reduced |
| Citigroup Inc | 99,625 | $160.4K | 0.00% | +93,485+1,522.6% | Added |
| Bridgeway Capital Management, LLC | 105,300 | $169.5K | 0.00% | 00.0% | Unchanged |
| Trustees of Columbia University in the City of New York | 113,850 | $183.0K | 0.38% | +113,850 | New |
| Susquehanna International Group, LLP | 146,059 | $235.2K | 0.00% | +128,086+712.7% | Added |
| State Street Corp | 152,129 | $244.9K | 0.00% | +38,271+33.6% | Added |
| Mayo Clinic | 479,242 | $771.6K | 0.41% | +479,242 | New |
| Geode Capital Management, LLC | 607,443 | $977.0K | 0.00% | +20,960+3.6% | Added |
| Alphabet Inc. | 1,060,495 | $1.71M | 0.10% | 00.0% | Unchanged |
| BlackRock Inc. | 1,232,681 | $1.98M | 0.00% | +27,315+2.3% | Added |
| CVI Holdings, LLC | 1,471,572 | $2.37M | 0.30% | −222,083−13.1% | Reduced |
| HarbourVest Partners LLC | 3,063,505 | $4.93M | 1.65% | 00.0% | Unchanged |
| Vanguard Group Inc | 3,168,375 | $5.10M | 0.00% | −54,045−1.7% | Reduced |
| Credit Suisse AG | 3,678,388 | $5.92M | 0.01% | +8,210+0.2% | Added |
| State of Michigan Retirement System | 4,070,728 | $6.55M | 0.05% | 00.0% | Unchanged |
| FMR LLC | 16,428,351 | $26.4M | 0.00% | +229,296+1.4% | Added |
| Flagship Pioneering Inc. | 50,427,328 | $81.2M | 2.59% | 00.0% | Unchanged |
| Ergoteles LLC | 0 | $0 | 0.00% | −27,429−100.0% | Sold out |
| Occudo Quantitative Strategies LP | 0 | $0 | 0.00% | −25,346−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −19,100−100.0% | Sold out |
| Cresset Asset Management, LLC | 0 | $0 | 0.00% | −18,366−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −11,082−100.0% | Sold out |
| LMR Partners LLP | 0 | $0 | 0.00% | −10,833−100.0% | Sold out |